| About CIHR |
| CIHR Institutes |
| Funding Health Research |
| Knowledge Translation and Commercialization |
| Partnerships |
| Major Strategic Initiatives |
| International Cooperation |
| Ethics |
| News and Media |
| Publications |
Listening for Direction On Injury (LFD-Injury) is a multi-institute strategic initiative of CIHR developed to bring together leading Canadian researchers and decision makers to identify strategic priorities for research, capacity building, knowledge translation and infrastructure support for the management of Injury. These individuals represent the four content areas (unintentional injury prevention, intentional injury prevention, acute care, and rehabilitation) that dominate research in Injury Control. LFD-Injury aims to increase the understanding of injury and its intervention through workshops, publications, and research opportunities. For more information, visit LFD-Injury on the web.
Listening for Direction On Injury (LFD-Injury) multi-institute initiative is co-championed by the Institute of Health Services and Policy Research (IHSPR) and the Institute of Musculoskeletal Health and Arthritis (IMHA), in partnership with the Canadian Injury Research Network (CIRNet), SMARTRISK and the Insurance Bureau of Canada (IBC).The LFD-Injury process involved eighteen months of research, consultation, publications and workshops. The key findings of this work can be found in the 2004 Executive Summary Report . The 2004 final report is available on the Injury Prevention Strategy website.
After a successful review of the findings, the scientific directors of CIHR have agreed to fund the next phase of LFD-Injury in partnership with SMARTRISK and others. This second phase is proceeding as outlined in the 2004 final report, with two major goals, the drafting of Requests for Applications (RFAs) and the development of a partnership strategy for the creation and funding of up to five Community Alliance Health Research Centres in Phase III: 2006. Dr. Cam Mustard and Dr. Rob Brison have agreed to continue to shepherd the process as co-chairs of the management team. Other members of the Scientific Advisory Committee and report authors from Phase I have agreed to remain involved in a consultative role. Additional details will follow as they become available.
